Study shows hospital antibiotics gave rise to spread of superbug
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Widespread use of antibiotics in hospitals triggered the emergence of two resistant strains of the Clostridium superbug which has killed thousands of people worldwide over the past two decades, a study has shown.
A genetic analysis of about 300 samples of Clostridium difficile bacteria from around the world found that the global outbreaks were caused by two different strains that had independently acquired resistance to an antibiotic widely used in hospitals.
Scientists traced the evolutionary trees of each strain of C. difficile and found that both originated within a couple of years of each other, one in a hospital in Pittsburg, Pennsylvania, and the other in Montreal, Canada.
International travellers carried the Canadian strain to Britain and the rest of Europe, where it caused a notorious series of outbreaks in UK hospitals between 2003 and 2006, leading to hundreds of patients dying from bowel complications.
"We used advanced DNA sequencing to determine the evolutionary history of this epidemic and the subsequent pattern of global spread," said Miao He of the Wellcome Trust Sanger Institute in Cambridge, which carried out the genetic analysis.
"We found that this outbreak came from two separate epidemic strains or lineages of C. difficile, both emerging from North America over a very short period, and rapidly spread between hospitals around the world."
The study found that both strains of bacteria had undergone the same tiny mutation in a key gene that conferred resistance to the antibiotic fluoroquinolone.
Trevor Lawley, the leader of the study at the Sanger Institute, said: "Until this research, we didn't realise that the same mutation had actually happened twice – independently of one another. It shows that this is not a rare event and can happen again.
"There is a link between acquiring resistance and appearance of these mutations around the world, and the use of the antibiotics."
The study, published in the journal Nature Genetics, said the evolution and persistence of fluoroquinolone-resistant strains of C. difficile was likely to be the result of widespread use of this class of antibiotics in North America in the late 1990s and early 2000s.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments